These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5780259)

  • 21. Coagulase-negative staphylococcus.
    Andriole VT; Lyons RW
    Ann N Y Acad Sci; 1970 Oct; 174(2):533-44. PubMed ID: 5278134
    [No Abstract]   [Full Text] [Related]  

  • 22. Coagulase-negative staphylococci.
    Brumfitt W; Hamilton-Miller JM
    Int J Dermatol; 1983 May; 22(4):232-4. PubMed ID: 6862750
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antibiotic sensitivity of various Staphylococcus species isolated from newborn infants with purulent septic infections].
    Givental' NI; Cherkasskaia RS; Bogdanova LD; Vorob'eva LS; Semina NA
    Antibiotiki; 1983 Jun; 28(6):429-34. PubMed ID: 6881953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New quinolones against coagulase-negative Staphylococcus blood isolates: in vitro sensitivity and slime production.
    Santini C; Venditti M; Brandimarte C; Baiocchi P; Gelfusa V; Girmenia C; Micozzi A; Serra P
    J Chemother; 1989 Jul; 1(4 Suppl):374-5. PubMed ID: 16312446
    [No Abstract]   [Full Text] [Related]  

  • 25. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.
    Bourgeois I; Pestel-Caron M; Lemeland JF; Pons JL; Caron F
    Antimicrob Agents Chemother; 2007 Feb; 51(2):740-3. PubMed ID: 17116684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of coagulase-negative staphylococci in human disease.
    Piette A; Verschraegen G
    Vet Microbiol; 2009 Feb; 134(1-2):45-54. PubMed ID: 18986783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
    Kucukates E; Nalan Karayel E; Gultekin N; Okuyan E; Kansiz E; Gurler N
    Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323
    [No Abstract]   [Full Text] [Related]  

  • 28. Glycopeptides in the treatment of staphylococcal infections.
    Daschner FD; Kropec A
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulase negative Staphylococci as causative agents of urinary tract infections-prevalence and resistance status in IGIMS, Patna.
    Kumari N; Rai A; Jaiswal CP; Xess A; Shahi SK
    Indian J Pathol Microbiol; 2001 Oct; 44(4):415-9. PubMed ID: 12035353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Microbiological identification of coagulase-negative staphylococci and the present status of their sensitivity to antibiotics].
    Bébrová E; Nyc O
    Epidemiol Mikrobiol Imunol; 1994 Dec; 43(4):151-7. PubMed ID: 7850214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Coagulase-negative staphylococci in normal and chronically inflamed conjunctiva].
    Grasbon T; Miño de Kaspar H; Klauss V
    Ophthalmologe; 1995 Dec; 92(6):793-801. PubMed ID: 8563427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of daptomycin against staphylococci collected from bloodstream infections in Spanish medical centers.
    Picazo JJ; Betriu C; Culebras E; Rodríguez-Avial I; Gómez M; López F;
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):448-51. PubMed ID: 19631100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin.
    Alou L; Cafini F; Sevillano D; Unzueta I; Prieto J
    Int J Antimicrob Agents; 2004 May; 23(5):513-6. PubMed ID: 15120734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of methods for detecting oxacillin resistance in coagulase-negative staphylococci including cefoxitin disc diffusion.
    Palazzo IC; Darini AL
    FEMS Microbiol Lett; 2006 Apr; 257(2):299-305. PubMed ID: 16553867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Coagulase-negative staphylococci and the microbiological diagnosis of the diseases they cause (a review of the literature)].
    Kuz'minskiĭ SN; Znamenskiĭ VA
    Vrach Delo; 1982 Aug; (8):112-5. PubMed ID: 7147866
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
    Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
    Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Report on 4,000 hemo-ovocultures].
    Nativelle R; Deparis M
    Presse Med (1893); 1970 Jan; 78(3):131-2. PubMed ID: 4907362
    [No Abstract]   [Full Text] [Related]  

  • 38. Significance of coagulase-negative staphylococci in urinary tract infections in a developing country.
    Orrett FA; Shurland SM
    Conn Med; 1998 Apr; 62(4):199-203. PubMed ID: 9611415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study in staphylococci of the production of a deoxyribonuclease with other tests of pathogenicity].
    Henri P; Cluzel M; Ourceyre C; Cluzel R
    C R Seances Soc Biol Fil; 1968; 162(2):444-7. PubMed ID: 4236630
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antibiotic sensitivity of plasmonegative and plasmopositive staphylococci isolated from patients in 1970-1977].
    Val'vachev NI; Zhizhel' AO
    Antibiotiki; 1980 Mar; 25(3):185-8. PubMed ID: 7362223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.